MIT Center Celebrates a Decade of Cancer Nanomedicine

At the Broad Institute and Koch Institute in Cambridge, Massachusetts, the Marble Center for Cancer Nanomedicine recently celebrated its tenth anniversary. Sangeeta Bhatia, faculty director of the center, hosted researchers, entrepreneurs, and clinicians to reflect on a decade of work miniaturizing solutions for cancer detection and treatment. The center, established in 2016 with a gift from Kathy and Curt Marble, now includes faculty from multiple MIT departments and has trained nearly 500 researchers.

Twenty-three startup companies have emerged from the Marble Center’s laboratories, including Matrisome Bio and Amplifyer Bio, each developing novel approaches to cancer therapy and diagnostics. Panelists at the event discussed challenges in translating lab research into commercial products, emphasizing the need for focus and reproducible results.

The center plans to launch a new grant program, Integrated Nanoscale Sensing, Imaging, and Health Technologies, to further advance precision medicine. While significant progress has been made, panelists noted that scaling up and ensuring reproducibility remain key hurdles for nanomedicine startups. The work to refine and implement these technologies continues.